# Safety and pharmacokinetics of a biosimilar of denosumab (KN012): Phase 1 and bioequivalence study in healthy Chinese subjects

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-pharmacokinetics-of-a-biosimilar-of-denosumab-kn012-phase-1-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hong Zhang,Cuiyun Li,Jingrui Liu,Min Wu,Xiaojiao Li,Xiaoxue Zhu,Qianqian Li,Boguang Wang,Yanhong Mao,Yanhua Ding,Qinglong Jin |
| Citations | 16 |
| DOI | 10.1080/13543784.2021.1863371 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3113145543 |
| PMID | 33306418 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Xiaojiao Li](https://scholariq.org/researchers/xiaojiao-li/)

## Paper journal

- [Expert Opinion on Investigational Drugs](https://scholariq.org/journals/expert-opinion-on-investigational-drugs/)

## Paper primary topic

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Paper topics

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.